Thursday , December 14 2017
Home / Letter From The Editor (page 11)

Letter From The Editor

Jan. 10, 2017

Five or six years ago, the widespread advertising of $4 dollar drug programs was in the wheelhouse of every pharmacy, and there were hundreds of drugs on the list. Since then the list has gotten much shorter and the number of pharmacies advertising them has decreased. Part of the reason …

Read More »

Jan. 7, 2017

The ADA has announced their new Standards of Care for 2017 and they are taking a more global approach to A1C, CVD and hypoglycemia. When it comes to CVD, there is a bigger push to get patients to improve blood pressure levels. They recommend more widespread use of ARB’s and …

Read More »

Jan. 3, 2017

This morning I was listening to my local NPR station, and although they don’t have advertising like a regular station, they do have sponsors. One sponsor, a major vitamin and nutrition company, was making a big deal about new products and new programs for the new year. I knew that …

Read More »

Dec. 31, 2016

The bowl games have already started, the new year has been rung in, and now it is time to get back to work and help our patients. The top 4 teams in college football are paired up for the NCAA Football championship, and one of them will definitely be proclaimed …

Read More »

Dec. 27, 2016

When we publish clinical information most of the time it is a study where the parameters are closely controlled. This means that often the human factor is not included in the results. These human factors could be as simple as missing a dose, but even more likely these problems are …

Read More »

Dec. 24, 2016

Over the past year we have provided you with over 850 articles, interviews, best products, snippets of knowledge, tests of knowledge, and educational videos. Each and every week our staff looks over the latest and greatest in diabetes care, and we select what we think you will be most interested …

Read More »

Dec. 20, 2016

Happy Holidays from all of us here at Diabetes In Control. Dr. Jeffrey Mechanick, from the  Icahn School of Medicine at Mount Sinai, NY, was chosen president of the American College of Endocrinology this past year and played a big role in new Joint A1c recommendations. He has been chatting …

Read More »

Dec. 19, 2016

When we began 2016, we were just starting to see the value of the SGLT-2 Inhibitors gain momentum. In fact, our first feature of the year looked at mixing an SGLT-2 Inhibitor with a DPP-4i and Metformin to maximize glucose control, and over the year we reviewed over 40 articles and …

Read More »

Dec. 17, 2016

When you think of the holidays, everyone’s mind often drifts to gifts, whether it is a husband thinking what to get his wife or a child thinking about a new game they have to have. Regardless of whether you are are on the giving or receiving side, it would be …

Read More »

Dec. 15, 2016

Recently the ADA and the AHA came together to adjust the guidelines in diabetes patients with cardiovascular problems. They have agreed that managing the cardiovascular problems should be the guiding light in overall patient care, and worrying about A1c levels is of less importance. This is especially true in older patients. …

Read More »